WHS Ranks Topical Oxygen Level 1 Evidence

By NS Healthcare Staff Writer 16 Apr 2024

Exciting news in the realm of wound care! The Wound Healing Society has recently increased topical oxygen therapy to 'Level 1' evidence in its updated DFU treatment guidelines, signifying a significant leap in the field.

Pharmaceuticals

Patient Care

Nutraceuticals

WHS Ranks Topical Oxygen Level 1 Evidence

Genentech’s Columvi meets primary endpoint in Phase 3....

Cepheid Announces World Health Organization Prequalification of Xpert....

Greenspace and Welligent partner to improve behavioural healthcare

Meridian Bioscience Drives Democratization of Next-Generation Sequencing (NGS)....

Pharmaceuticals

Merck KGaA, Caris enter potential $1.4bn deal to develop ADCs for cancer
05 Apr 24

FDA approves Basilea’s antibiotic Zevtera for three indications
04 Apr 24

Ipsen licenses Sutro Biopharma’s ADC STRO-003 in deal worth up to $900m
02 Apr 24

Patient Care

Genmab to acquire ADC developer ProfoundBio for $1.8bn
03 Apr 24

Eisai submits sBLA to FDA for Leqembi IV maintenance dosing in Alzheimer’s
01 Apr 24

FDA approves Akebia Therapeutics’ Vafseo for anaemia caused by CKD
28 Mar 24

Nutraceuticals

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects
05 Apr 24

Arla Foods announces plans to become major UK exporter of mozzarella
05 Apr 24

Davos Life Science achieves FSSC 22000 certification, demonstrating unwavering commitment to food safety excellence
05 Apr 24

NS Healthcare is using cookies

Merck KGaA, Caris enter potential $1.4bn deal to develop ADCs for cancer05 Apr 24

FDA approves Basilea’s antibiotic Zevtera for three indications04 Apr 24

Ipsen licenses Sutro Biopharma’s ADC STRO-003 in deal worth up to $900m02 Apr 24

Genmab to acquire ADC developer ProfoundBio for $1.8bn 03 Apr 24

Eisai submits sBLA to FDA for Leqembi IV maintenance dosing in Alzheimer’s 01 Apr 24

FDA approves Akebia Therapeutics’ Vafseo for anaemia caused by CKD 28 Mar 24

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects05 Apr 24

Arla Foods announces plans to become major UK exporter of mozzarella05 Apr 24

Davos Life Science achieves FSSC 22000 certification, demonstrating unwavering commitment to food safety excellence05 Apr 24

OUR TITLES

Proprio and Biedermann collaborate on AI-powered....10 Apr 24

Oxford Properties starts work on Ionis....06 Dec 23

Healthpeak to merge with Physicians Realty....31 Oct 23

PepsiCo Beverage’s Sacramento-Based Electric Fleet Is....29 Sep 23

Novo Nordisk to buy cardiovascular drugmaker....26 Mar 24

Nuvation Bio to acquire oncology firm....26 Mar 24

AbbVie to acquire clinical-stage firm Landos....26 Mar 24

LENZ Therapeutics announces completion of merger....22 Mar 24

Neomorph, Novo Nordisk enter $1.46bn partnership....27 Feb 24

AbbVie, Tentarix partner to develop oncology....23 Feb 24

General Dynamics unit wins $2.5bn contract....14 Nov 23

SGC, HitGen collaborate on DEL technology....29 Sep 23

Merck KGaA, Caris enter potential $1.4bn deal to develop ADCs for cancer
05 Apr 24

FDA approves Basilea’s antibiotic Zevtera for three indications
04 Apr 24

Ipsen licenses Sutro Biopharma’s ADC STRO-003 in deal worth up to $900m
02 Apr 24

Genmab to acquire ADC developer ProfoundBio for $1.8bn
03 Apr 24

Eisai submits sBLA to FDA for Leqembi IV maintenance dosing in Alzheimer’s
01 Apr 24

FDA approves Akebia Therapeutics’ Vafseo for anaemia caused by CKD
28 Mar 24

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects
05 Apr 24

Arla Foods announces plans to become major UK exporter of mozzarella
05 Apr 24

Davos Life Science achieves FSSC 22000 certification, demonstrating unwavering commitment to food safety excellence
05 Apr 24

Proprio and Biedermann collaborate on AI-powered....
10 Apr 24

Oxford Properties starts work on Ionis....
06 Dec 23

Healthpeak to merge with Physicians Realty....
31 Oct 23

PepsiCo Beverage’s Sacramento-Based Electric Fleet Is....
29 Sep 23

Novo Nordisk to buy cardiovascular drugmaker....
26 Mar 24

Nuvation Bio to acquire oncology firm....
26 Mar 24

AbbVie to acquire clinical-stage firm Landos....
26 Mar 24

LENZ Therapeutics announces completion of merger....
22 Mar 24

Neomorph, Novo Nordisk enter $1.46bn partnership....
27 Feb 24

AbbVie, Tentarix partner to develop oncology....
23 Feb 24

General Dynamics unit wins $2.5bn contract....
14 Nov 23

SGC, HitGen collaborate on DEL technology....
29 Sep 23